Narya Capital

Narya Capital operates as an early-stage venture capital firm, investing in companies that leverage technology and science to address significant national challenges. It prioritizes innovative solutions across critical sectors including healthcare, food production, advanced therapies, and national defense, focusing on foundational advancements rather than incremental technological changes.

James David Vance and Colin Greenspon co-founded Narya Capital in 2019. Their insight emphasized redirecting venture capital towards impactful, foundational innovation for core American problems. Vance, known for his perspective on societal issues, collaborated with Greenspon, an experienced venture professional, to establish this mission-driven firm.

Narya Capital's portfolio companies serve diverse customers, from individuals seeking accessible healthcare and insurance to organizations requiring robust defense technologies. The firm envisions cultivating businesses that enhance national resilience and improve citizens' quality of life through strategic applications of science and technology.